The immunosuppressive effect of domain-deleted dimer of HLA-G2 isoform in collagen-induced arthritis mice

被引:16
作者
Takahashi, Ami [1 ]
Kuroki, Kimiko [1 ]
Okabe, Yuki [1 ]
Kasai, Yoshiyuki [1 ]
Matsumoto, Naoki [2 ]
Yamada, Chisato [1 ]
Takai, Toshiyuki [3 ]
Ose, Toyoyuki [1 ]
Kon, Shigeyuki [2 ]
Matsuda, Tadashi [2 ]
Maenaka, Katsumi [1 ,4 ]
机构
[1] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biomol Sci, Sapporo, Hokkaido, Japan
[2] Hokkaido Univ, Fac Pharmaceut Sci, Dept Immunol, Sapporo, Hokkaido, Japan
[3] Tohoku Univ, IDAC, Dept Expt Immunol, Sendai, Miyagi, Japan
[4] Hokkaido Univ, Fac Pharmaceut Sci, Ctr Res & Educ Drug Discovery, Sapporo, Hokkaido, Japan
关键词
HLA-G2; LILRB2/ILT4; PIR-B; CIA mice; Immunosuppression; ANTIGEN-PRESENTING CELLS; CD4(+) T-CELLS; BINDING; INHIBITION; SUPPRESSES; MATURATION; RESPONSES; RECEPTOR; PROTEIN;
D O I
10.1016/j.humimm.2016.01.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HLA-G is involved in maternal-fetal immune tolerance and is reported to be a natural tolerogenic molecule. Seven-spliced isoforms including dimeric and beta 2m-free forms have been identified. The major isoform, HLA-G1 (and its soluble type HLA-G5), binds to the inhibitory immune receptors, leukocyte immunoglobulin (Ig)-like receptor (LILR) B1 and LILRB2. We previously reported that HLA-G1 also binds to paired Ig-like receptor (PIR)-B, a mouse homolog of LILRBs, and had a significant immunosuppressive effect in collagen-induced arthritis (CIA) mice. Although HLA-G2 and its soluble form HLA-G6 bind specifically to LILRB2, its functional characteristics are largely unknown. In this study, we report the significant immunosuppressive effect of HLA-G2 dimer in CIA mice. Surface plasmon resonance analysis revealed a specific interaction of HLA-G2 with PIR-B. CIA mice were administered HLA-G2 protein subcutaneously once in the left footpad and clinical severity was evaluated in a double-blind study. A single administration of HLA-G2 maintained a suppressive effect for over 1 month. These results suggested that the HLA-G2 protein might be a useful biopharmaceutical for the treatment of rheumatoid arthritis by binding to inhibitory PIR-B. (C) 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:754 / 759
页数:6
相关论文
共 23 条
  • [21] Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G
    Shiroishi, M
    Tsumoto, K
    Amano, K
    Shirakihara, Y
    Colonna, M
    Braud, VM
    Allan, DSJ
    Makadzange, A
    Rowland-Jones, S
    Willcox, B
    Jones, EY
    van der Merwe, PA
    Kumagai, I
    Maenaka, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (15) : 8856 - 8861
  • [22] Impaired dendritic cell maturation and increased TH2 responses in PIR-B-/- mice
    Ujike, A
    Takeda, K
    Nakamura, A
    Ebihara, S
    Akiyama, K
    Takai, T
    [J]. NATURE IMMUNOLOGY, 2002, 3 (06) : 542 - 548
  • [23] HLA-G1 and HLA-G5 isoforms have an additive effect on NK cytolysis
    Zhang, Wei-Qun
    Xu, Dan-Ping
    Liu, Di
    Li, Ying-Ying
    Ruan, Yan-Yun
    Lin, Aifen
    Yan, Wei-Hua
    [J]. HUMAN IMMUNOLOGY, 2014, 75 (02) : 182 - 189